The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis

S Debette, HS Markus - Bmj, 2010 - bmj.com
Objectives To review the evidence for an association of white matter hyperintensities with
risk of stroke, cognitive decline, dementia, and death. Design Systematic review and meta …

White matter hyperintensities, cognitive impairment and dementia: an update

ND Prins, P Scheltens - Nature Reviews Neurology, 2015 - nature.com
White matter hyperintensities (WMHs) in the brain are the consequence of cerebral small
vessel disease, and can easily be detected on MRI. Over the past three decades, research …

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

JM Wardlaw, EE Smith, GJ Biessels… - The Lancet …, 2013 - thelancet.com
Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features seen
on neuroimaging include recent small subcortical infarcts, lacunes, white matter …

Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly

A Cattaneo, N Cattane, S Galluzzi, S Provasi… - Neurobiology of …, 2017 - Elsevier
The pathway leading from amyloid-β deposition to cognitive impairment is believed to be a
cornerstone of the pathogenesis of Alzheimer's disease (AD). However, what drives amyloid …

Post-stroke dementia–a comprehensive review

MD Mijajlović, A Pavlović, M Brainin, WD Heiss… - BMC medicine, 2017 - Springer
Post-stroke dementia (PSD) or post-stroke cognitive impairment (PSCI) may affect up to one
third of stroke survivors. Various definitions of PSCI and PSD have been described. We …

National Institute of Neurological Disorders and Stroke–Canadian stroke network vascular cognitive impairment harmonization standards

V Hachinski, C Iadecola, RC Petersen, MM Breteler… - Stroke, 2006 - Am Heart Assoc
Background and Purpose—One in 3 individuals will experience a stroke, dementia or both.
Moreover, twice as many individuals will have cognitive impairment short of dementia as …

Plasma β-amyloid in Alzheimer's disease and vascular disease

S Janelidze, E Stomrud, S Palmqvist, H Zetterberg… - Scientific reports, 2016 - nature.com
Implementation of amyloid biomarkers in clinical practice would be accelerated if such
biomarkers could be measured in blood. We analyzed plasma levels of Aβ42 and Aβ40 in a …

Diagnostic criteria for vascular cognitive disorders: a VASCOG statement

P Sachdev, R Kalaria, J O'Brien, I Skoog… - Alzheimer Disease & …, 2014 - journals.lww.com
Background: Several sets of diagnostic criteria have been published for vascular dementia
since the 1960s. The continuing ambiguity in vascular dementia definition warrants a critical …

Long COVID‐19: Objectifying most self‐reported neurological symptoms

J Bungenberg, K Humkamp… - Annals of clinical …, 2022 - Wiley Online Library
Objectives We aimed to objectify and compare persisting self‐reported symptoms in initially
hospitalized and non‐hospitalized patients after infection with severe acute respiratory …

White matter hyperintensities and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 36 prospective studies

HY Hu, YN Ou, XN Shen, Y Qu, YH Ma, ZT Wang… - Neuroscience & …, 2021 - Elsevier
Background White matter hyperintensities of presumed vascular origin (WMH) are one of the
imaging features of cerebral small vessel disease. Controversies persist about the effects of …